Sign in
Explore the registryTrack Rsvpref3 oa investigational vaccine's trials

Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

RSVPreF3 OA investigational vaccineOngoingActive not recruitingPhase 3Open NCT04732871 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…